Jill P. Buyon

38.1k total citations · 3 hit papers
320 papers, 17.1k citations indexed

About

Jill P. Buyon is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jill P. Buyon has authored 320 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 222 papers in Rheumatology, 150 papers in Immunology and 80 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jill P. Buyon's work include Systemic Lupus Erythematosus Research (216 papers), Monoclonal and Polyclonal Antibodies Research (75 papers) and Cell Adhesion Molecules Research (65 papers). Jill P. Buyon is often cited by papers focused on Systemic Lupus Erythematosus Research (216 papers), Monoclonal and Polyclonal Antibodies Research (75 papers) and Cell Adhesion Molecules Research (65 papers). Jill P. Buyon collaborates with scholars based in United States, United Kingdom and Canada. Jill P. Buyon's co-authors include Robert M. Clancy, Deborah Friedman, Mimi Kim, Peter Izmirly, Steven B. Abramson, Michelle Petri, Joan T. Merrill, Edward K. L. Chan, Joshua A. Copel and Anca Askanase and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jill P. Buyon

313 papers receiving 16.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis

2005 766 citations Mimi Kim, Jill P. Buyon et al. profile →
Predictors of Pregnancy Outcomes in Patients With Lupus

2015 359 citations Jill P. Buyon, Mimi Kim et al. profile →
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

2019 302 citations Doua F. Azzouz, Adriana Heguy et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill P. Buyon United States	74	9.8k	7.1k	3.1k	2.9k	2.0k	320	17.1k
Anǵela Tincani Italy	71	15.0k 1.5×	7.2k 1.0×	1.2k 0.4×	2.9k 1.0×	1.5k 0.7×	451	21.3k
Jane E. Salmon United States	66	7.8k 0.8×	6.8k 1.0×	1.2k 0.4×	1.2k 0.4×	1.7k 0.8×	211	14.6k
Michael D. Lockshin United States	52	13.0k 1.3×	5.2k 0.7×	1.6k 0.5×	2.0k 0.7×	840 0.4×	182	17.0k
Munther A. Khamashta United Kingdom	84	22.6k 2.3×	10.1k 1.4×	1.6k 0.5×	4.1k 1.4×	1.8k 0.9×	411	31.3k
Graham R.V. Hughes United Kingdom	68	13.6k 1.4×	4.4k 0.6×	1.1k 0.4×	2.5k 0.9×	1.2k 0.6×	263	18.2k
Murray B. Urowitz Canada	73	16.3k 1.7×	9.9k 1.4×	1.4k 0.5×	3.5k 1.2×	1.5k 0.7×	360	19.6k
Tatsuya Atsumi Japan	51	9.5k 1.0×	4.2k 0.6×	739 0.2×	1.5k 0.5×	1.8k 0.9×	512	15.5k
Naomi F. Rothfield United States	48	12.7k 1.3×	7.8k 1.1×	745 0.2×	4.1k 1.4×	2.7k 1.4×	125	19.8k
É. Hachulla France	78	6.1k 0.6×	4.3k 0.6×	1.8k 0.6×	867 0.3×	3.4k 1.7×	677	22.4k
Mary K. Crow United States	66	7.7k 0.8×	8.5k 1.2×	915 0.3×	1.6k 0.6×	2.4k 1.2×	184	14.4k

Countries citing papers authored by Jill P. Buyon

Since Specialization

Citations

This map shows the geographic impact of Jill P. Buyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill P. Buyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill P. Buyon more than expected).

Fields of papers citing papers by Jill P. Buyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill P. Buyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill P. Buyon. The network helps show where Jill P. Buyon may publish in the future.

Co-authorship network of co-authors of Jill P. Buyon

This figure shows the co-authorship network connecting the top 25 collaborators of Jill P. Buyon. A scholar is included among the top collaborators of Jill P. Buyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill P. Buyon. Jill P. Buyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abheiden, Carolien N. H., Johannes C. F. Ket, Jane E. Salmon, et al.. (2024). Systemic lupus erythematosus is associated with an increased frequency of spontaneous preterm births: systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 231(4). 408–416.e21. 1 indexed citations

Carlucci, Philip M., Mala Masson, Amit Saxena, et al.. (2024). Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia. ACR Open Rheumatology. 6(4). 172–178. 4 indexed citations

Azzouz, Doua F., Ze Chen, Peter Izmirly, et al.. (2023). Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares. Annals of the Rheumatic Diseases. 82(10). 1315–1327. 33 indexed citations

Barrett, Tessa J., Jeffrey S. Berger, Christina C. Rolling, et al.. (2023). P2Y12 Inhibition Suppresses Proinflammatory Platelet–Monocyte Interactions. Thrombosis and Haemostasis. 123(2). 231–244. 21 indexed citations

Kaizer, Alexander, Robert M. Clancy, Anne E. Tebo, et al.. (2022). Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers. American Journal of Obstetrics and Gynecology. 227(5). 761.e1–761.e10. 7 indexed citations

Friedman, Deborah, Mimi Kim, N. Costedoat‐Chalumeau, et al.. (2020). Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation. Circulation Arrhythmia and Electrophysiology. 13(10). e008686–e008686. 20 indexed citations

Azzouz, Doua F., Adriana Heguy, Dominik Schwudke, et al.. (2019). Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Annals of the Rheumatic Diseases. 78(7). 947–956. 302 indexed citations breakdown →

Hui‐Yuen, Joyce, Jennifer Taylor, Xiaoqing Li, et al.. (2015). Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices. The Journal of Rheumatology. 42(12). 2288–2295. 75 indexed citations

Kalunian, Kenneth, Winn Chatham, Elena Massarotti, et al.. (2012). Measurement of cell‐bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis & Rheumatism. 64(12). 4040–4047. 62 indexed citations

10.

Reed, Joanne H., Robert M. Clancy, Anthony W. Purcell, et al.. (2011). β2-Glycoprotein I and Protection from Anti-SSA/Ro60–Associated Cardiac Manifestations of Neonatal Lupus. The Journal of Immunology. 187(1). 520–526. 21 indexed citations

11.

Brucato, Antonio, Véronique Ramoni, Silvana Penco, et al.. (2010). Passively acquired anti‐SSA/Ro antibodies are required for congenital heart block following ovodonation but maternal genes are not. Arthritis & Rheumatism. 62(10). 3119–3121. 7 indexed citations

12.

Clancy, Robert M., David Álvarez, Elena V. Komissarova, et al.. (2010). Ro60-Associated Single-Stranded RNA Links Inflammation with Fetal Cardiac Fibrosis via Ligation of TLRs: A Novel Pathway to Autoimmune-Associated Heart Block. The Journal of Immunology. 184(4). 2148–2155. 75 indexed citations

13.

Clancy, Robert M., Chelsea B. Backer, Xiao‐Ming Yin, et al.. (2003). Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-α and TGF-β1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block. The Journal of Immunology. 171(6). 3253–3261. 77 indexed citations

14.

Wang, Dunrui, et al.. (2001). Leucine zipper domain of 52 kDa SS-A/Ro promotes protein dimer formation and inhibits in vitro transcription activity. Biochimica et Biophysica Acta (BBA) - General Subjects. 1568(2). 155–161. 19 indexed citations

15.

Miranda‐Carús, María‐Eugenia, Anca Askanase, Robert M. Clancy, et al.. (2000). Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-α by Macrophages. The Journal of Immunology. 165(9). 5345–5351. 143 indexed citations

16.

Buyon, Jill P., Rudi Hiebert, Joshua A. Copel, et al.. (1999). Autoimmune-Associated Congenital Heart Block. Obstetrical & Gynecological Survey. 54(1). 13–15. 1 indexed citations

17.

Miranda, Marcela, Chung‐E Tseng, William K. Rashbaum, et al.. (1998). Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes.. PubMed. 161(9). 5061–9. 106 indexed citations

18.

Buyon, Jill P.. (1997). Autoantibodies reactive with Ro(SSA) and La(SSB) and pregnancy.. PubMed. 50. 12–6. 8 indexed citations

19.

Friedman, Deborah, et al.. (1995). Benign Fetal Bradycardias Diagnosed by Echocardiography. American Journal of Perinatology. 12(2). 87–90. 8 indexed citations

20.

Buyon, Jill P., Steven B. Abramson, Mark R. Philips, et al.. (1988). Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregation.. The Journal of Immunology. 140(9). 3156–3160. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact